Home World Covid, a second antiviral is being studied in the US. Here’s how it works and when it will come to us

Covid, a second antiviral is being studied in the US. Here’s how it works and when it will come to us

by admin

The second antiviral drug against the Covid has begun the exams for approval in the US. Is called Paxlovid and was developed by Pfizer. A first drug of this type has already been approved in Great Britain on 4 November. Is called Molnupiravir, is produced by Merck (known in Italy as Msd) and is being evaluated since October both at the Emma (European Medicines Agency) and at l’fda, la Food and Drug Administration americana.

.

See also  In Tajikistan the center of the Afghan resistance against the Taliban. But the road is uphill, there is a lack of international allies
0 comment
0

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy